Novel Drug Combination Achieves 83% Remission Rate in High-Risk Leukemia
University of Hong Kong researchers demonstrate that novel QUIZOM combination therapy achieves 83% complete remission rate in high-risk FLT3-mutated acute…
Editor's Top Picks
Childhood junk food may permanently rewire brain appetite circuits, study finds
New research reveals that consuming junk food during childhood may permanently alter brain circuits controlling appetite, with effects persisting into…
Submit Your Paper to GMJ
Dexcom Signals Expansion Beyond Diabetes as CGM Technology Reshapes Health Monitoring
Dexcom's leadership has signalled plans to expand continuous glucose monitoring beyond diabetes management into weight and metabolic health applications. The…
TrumpRx Expands Generic Drug Portfolio Through Amazon Pharmacy and GoodRx Partnership
TrumpRx has partnered with Amazon Pharmacy and GoodRx to expand into generic medications, signaling a major shift in its pharmaceutical…
New R&D Ranking Reveals Sharp Disparities in Pharmaceutical Innovation Efficiency
A new evidence-based ranking of pharmaceutical companies reveals significant disparities in how efficiently firms convert R&D spending into drug approvals.…
New treatment approach offers hope for pre-eclampsia, a leading cause of maternal death
Pre-eclampsia causes more than 70,000 maternal deaths annually worldwide. Researchers are now investigating novel therapeutic approaches targeting placental dysfunction and…
Why Some Cancers Evade Chemotherapy: New Mechanism Identified
Researchers have identified a molecular mechanism that enables cancer cells to survive chemotherapy, revealing how 30–40% of treated tumors develop…
How Muscle Really Grows: Exercise Triggers Protein Synthesis, Not Just Microscopic Tears
Research now shows that muscle growth is driven primarily by elevated protein synthesis triggered by mechanical tension, not by microscopic…